Ticker Details
Heron Therapeutics, Inc. Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
IPO Date:	January 23, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$84.32M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 3.50%
Avg Daily Range (30 D):	$0.03 | 5.99%
Avg Daily Range (90 D):	$0.04 | 4.91%

Institutional Daily Volume
Avg Daily Volume:	1.31M
Avg Daily Volume (30 D):	3.88M
Avg Daily Volume (90 D):	2.65M

Trade Size
Avg Trade Size (Sh.):	170
Avg Trade Size (Sh.) (30 D):	413
Avg Trade Size (Sh.) (90 D):	344

Institutional Trades
Total Institutional Trades:	3,474
Avg Institutional Trade:	$1.58M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$1.94M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.02M
Avg Closing Trade (30 D):	$.91M
Avg Closing Trade (90 D):	$.91M
Avg Closing Volume:	182.09K

News

Oct 29, 2025 @ 9:58 PM Heron Therapeutics Announces Appointment of Thomas... Source: Craig Collard

Oct 29, 2024 @ 8:05 PM Heron Therapeutics to Report Third Quarter 2024 Fi... Source: Prnewswire

Sep 17, 2024 @ 10:00 AM Chemotherapy Induced Nausea and Vomiting Treatment... Source: Fact.Mr

Jul 2, 2024 @ 12:43 PM Merck (MRK) Gets Exclusive Rights to Opevesostat F... Source: Zacks Equity Research

Jul 1, 2024 @ 2:31 PM FDA Rejects Rocket's (RCKT) Gene Therapy BLA for R... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.04	$-.01	$-.12
Diluted EPS	$-.04	$-.01	$-.12
Revenue	$34.71M	$40.59M	$154.9M
Gross Profit	$24.07M	$29.47M	$113.56M
Net Income / Loss	$-8.11M	$-2.95M	$-20.2M
Operating Income / Loss	$-4.77M	$.04M	$-2.54M
Cost of Revenue	$10.64M	$11.12M	$41.35M
Net Cash Flow	$-2.53M	$-14.42M	$2.85M
PE Ratio

Splits
Jan 13, 2014	1:20
May 25, 2007	1:4